Pancreatic Cancer Research

ResearcherDalhousie UniversityActive in the last 2 years

Thomas Samson

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0002-7340-5642; OpenAlex author ID A5124784114. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2025: 2 papers · 2026: 1 paper

Papers 3

  1. Preoperative Soluble AXL in Plasma Predicts Futility of Resecting Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/curroncol33020088↗
  2. Claudin 18 (43-14A clone) expression in pancreatic ductal adenocarcinoma: Assessment of a potential clinical biomarker for zolbetuximab therapy. Co-author DOI 10.1016/j.tranon.2025.102362↗
  3. Peri-tumoural lymphocyte neighbourhoods predict longer survival in pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fimmu.2025.1730817↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Thomas Arnason · 3 shared papers, 2025–2026 · strength 0.77
  2. Ravi Ramjeesingh · 3 shared papers, 2025–2026 · strength 0.77
  3. Boris Gala-López · 3 shared papers, 2025–2026 · strength 0.77
  4. Riley J. Arseneau · 2 shared papers, 2025 · strength 0.51
  5. Carley Bekkers · 2 shared papers, 2025 · strength 0.51
  6. Jeanette E. Boudreau · 2 shared papers, 2025–2026 · strength 0.50
  7. Sharon E. Clarke · 1 shared paper, 2026 · strength 0.26
  8. Stacey N. Lee · 1 shared paper, 2025 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.